Clinical Trial Detail

NCT ID NCT03691207
Title A Study Of AL101 In Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations (ACCURACY)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Ayala Pharmaceuticals, Inc,
Indications

adenoid cystic carcinoma

Therapies

BMS-906024

Age Groups: adult senior

Additional content available in CKB BOOST